We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PENN icon
51
PENN Entertainment
PENN
$2.63B
$25.1M 0.33%
1,377,037
+1,367,788
+14,788% +$28.2M
CPB icon
52
Campbell Soup
CPB
$6.87B
$24.5M 0.32%
+550,364
New +$23.8M
TOST icon
53
Toast
TOST
$20.2B
$23.3M 0.31%
934,687
-727,383
-44% -$15.1M
BILL icon
54
BILL Holdings
BILL
$4.81B
$23M 0.3%
334,063
+219,949
+193% +$15.4M
RIGL icon
55
Rigel Pharmaceuticals
RIGL
$749M
$22.7M 0.3%
1,536,000
-174,000
-10% -$2.34M
LOW icon
56
Lowe's Companies
LOW
$123B
$22.4M 0.3%
87,791
+18,693
+27% +$4.3M
SKX
57
DELISTED
Skechers
SKX
$22.3M 0.3%
364,340
+174,354
+92% +$10.6M
AMZN icon
58
Amazon
AMZN
$2.94T
$22.3M 0.3%
123,437
-329,855
-73% -$55.1M
XNCR icon
59
Xencor
XNCR
$1.47B
$22.1M 0.29%
1,000,000
-500,000
-33% -$10.8M
REGN icon
60
Regeneron Pharmaceuticals
REGN
$79.1B
$22.1M 0.29%
22,987
-37,013
-62% -$35.2M
ADBE icon
61
Adobe
ADBE
$103B
$22M 0.29%
43,626
+29,218
+203% +$16.7M
XOM icon
62
ExxonMobil
XOM
$628B
$22M 0.29%
+189,300
New +$19.8M
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$123B
$21.7M 0.29%
51,980
-46,020
-47% -$19.5M
ENTA icon
64
Enanta Pharmaceuticals
ENTA
$384M
$21.6M 0.29%
1,236,000
-828,000
-40% -$11M
BIIB icon
65
Biogen
BIIB
$30.5B
$21.6M 0.29%
100,049
-99,951
-50% -$23.4M
SWAV
66
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$21.5M 0.29%
66,169
-359,888
-84% -$88.4M
GOOGL icon
67
Alphabet (Google) Class A
GOOGL
$4.43T
$21.2M 0.28%
140,579
-355,421
-72% -$50.8M
MSFT icon
68
Microsoft
MSFT
$3.62T
$20.9M 0.28%
49,689
-112,304
-69% -$45.5M
FRPT icon
69
Freshpet
FRPT
$3.51B
$20.2M 0.27%
174,107
-629,151
-78% -$60.8M
CRL icon
70
Charles River Laboratories
CRL
$12.6B
$18.9M 0.25%
69,882
+33,882
+94% +$8.09M
KYNB
71
Kyntra Bio
KYNB
$28.3M
$18.6M 0.25%
317,440
-73,120
-19% -$3.15M
ALKS icon
72
Alkermes
ALKS
$8.32B
$18.2M 0.24%
672,218
-527,782
-44% -$15M
ROST icon
73
Ross Stores
ROST
$81.2B
$18.1M 0.24%
123,542
-1,168
-0.9% -$167K
SILK
74
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$17.5M 0.23%
956,000
-812,000
-46% -$12.9M
ISRG icon
75
Intuitive Surgical
ISRG
$133B
$17.2M 0.23%
42,977
+10,977
+34% +$4.15M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.